Leadership Team
Our executive team features a diverse group of experienced healthcare and technology professionals who help guide Glooko to drive superior innovation and commercial results
Russ Johannesson
Chief Executive Officer
Komathi Stem
Chief Operating Officer
Mark Clements, M.D., Ph.D.
Chief Medical Officer
Stephen Lien
Chief Financial Officer
Prakash Menon
Chief Technology Officer
David Conn
Executive Vice President of Partnerships & Alliances
Ed Marshall
Chief Product Officer
Board of Directors
Our Board of Directors is made up of industry executives and founders who support, advise and enable Glooko to be the leader in data management and remote patient monitoring for diabetes and other chronic conditions
Charles Boorady
Founder & Managing Partner, Health Catalyst Capital
Simon Chong
Co-Founder and Managing Partner, Georgian Partners
Wende Hutton
General Partner, Canaan Partners
Russ Johannesson
Chief Executive Officer, Glooko
Tracy Bahl
OneOncology, CVS, General Atlantic, Emdeon, UHG
Enrique Conterno
Former Eli Lilly & Company Senior Executive
Alfonso (Chito) Zulueta
Board Director of CTS Corp., Syneos Health, Inc., CALIDI BioTherapeutics;
Retired-President, International at Eli Lilly and Company
Yogen Dalal
Founder, Glooko
Board Observer
Medical Advisory Board
Mark Clements, M.D., Ph.D.
Glooko Chief Medical Officer, Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Pediatric Endocrinologist, Children’s Mercy Kansas City
Jerome Fischer, M.D.
Partner, Diabetes and Glandular Disease (DGD) Clinic
Michael Greenfield, M.D.
Endocrinologist, El Camino Hospital
David Kerr, M.D.
Director of Diabetes Research and Innovation, Sansum Diabetes Research Institute
